Certifications
Psychiatry, American Board of Psychiatry and Neurology
Neurology, American Board of Psychiatry and Neurology
Behavioral Neurology and Neuropsychiatry, United Council of Neurologic Subspecialties
Leadership
Residency Program Director
Member, LSUHSC Graduate Medical Education Committee
Gold Humanism Honor Society Inductee
Member, Program Director Leadership Group, Association of University
Neurology Professor
Publications
1. Varma-Doyle AV, Villemarette-Pittman NR,Copeland BJ.Hemi-parkinsonismand return of essential tremors after MRgFUS thalamotomy: Case report
andreview of procedural complications affecting ventral thalamicnuclei.eNeurologicalSci.2021
Apr12;23:100339.doi:10.1016/j.ensci.2021.100339. eCollection 2021 Jun.
2. Mader EC Jr, Rathore SH, England JD, Branch LA, Copeland BJ. Benzodiazepine Withdrawal Catatonia, Delirium, and Seizures in a Patient with Schizoaffective
Disorder. J Investig Med High Impact Case Rep 2020 Jan-Feb;8: 2324709620969498. PMID:
33138643
3. Cruz RA, Smith C, Ramos AB, Copeland BJ, and Seal PS. Intracranial Hypertension Secondary to Eosinophilic Meningitis by Angiostrongylus
Cantonensis: Case Report with Review of the Literature. J La State Med Soc 2018 May-June;170(3):83-87.
4. Lindsey E and Copeland BJ. Idiopathic basal ganglia calcifications: A case report and brief review of the literature,
(2015), J La State Med Soc 2016 Jan-Feb;168(1):29-31. PMID: 26986866
5. Copeland BJ, Fenoy A, Ellmore TM, Liang Q, Ephron V, and Schiess M. Deep brain stimulation of
the globus pallidus internus for generalized dystonia with spinocerebellar ataxia
type 1: a case report. Neuromodulation: Technology at the Neural Interface 2014 Jun;17(4):389-92.
PMID: 23815390
6. Copeland BJ and Schiess MC. Can mild cognitive impairment predict the development of dementia
in Parkinson’s disease? JAMA Neurology 2013;70(5):553. PMID: 23529474
Research
OPTI-ON: Opicapone Treatment Initiation Open-Label Study. Principle Site Investigator.
SPARX3: Study in Parkinson’s Disease of Exercise Phase 3 Clinical Trial. Co-Investigator.
Principle Investigator: Jan Hondzinski, PhD.
Assessing the potential of using ISGylation as a liquid biopsy biomarker for neurodegenerative
diseases. Co-Investigator. Principle Investigator: Shyamal Desai, PhD
Saccadic eye movements and cognition in neurological disorders. Co-Investigator. Principle
Investigator: Deidre Devier, PhD